US EditionThe rise of Ozempic is a convenient excuse for retailers to cut back on plus-size options
4 Articles
4 Articles
Ozempic, Wegovy, Mounjaro – these drugs have made headlines in recent years. They ensure a strong weight loss and side effects are kept within limits.
The rise of Ozempic is a convenient excuse for retailers to cut back on plus-size options
Getty Images; Rebecca Zisser/BITess Holliday remembers 2019 as a "glorious" year for plus-size fashion and body positivity. The plus-size model and body activist walked the runway at New York Fashion Week. She'd been featured by magazines such as Cosmopolitan UK, Nylon, and Self. The cultural shift felt palpable — Rihanna's Savage X Fenty runway show made headlines for the size diversity of its models, and Lizzo was topping the charts with catch…
The rise of Ozempic is a convenient excuse for retailers to cut back on plus-size options | The New York Ledger
Tess Holliday keeps in mind 2019 as a “wonderful” year for plus-size style and body positivity. The plus-size design and body activist strolled the runway at New york city Style Week. She ‘d been included by publications such as Cosmopolitan UK, Nylon, and Self. The cultural shift felt palpable– Rihanna’s Savage X Fenty runway program made headings for the size variety of its designs, and Lizzo was topping the charts with appealing tunes and a m…
Producing plus-size clothing presents unique operational challenges that many brands would prefer to avoid.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
